IMedis
AI-powered Quality Assurance Platform for Radiology
Company Overview
Snapshot
Founded in January 2018 by Aviel Blumenfeld and Yitzi Pfeffer, IMedis operates with over 1,000 employees. The company has raised $3.7 million across three funding rounds from ExitValley and Sanara Ventures. In January 2021, IMedis received CE approval for its radiology scans in the EU, marking a significant regulatory milestone.
Business overview
IMedis develops an AI-driven cloud-based quality management system specifically for radiology departments. Its core technology aggregates and analyzes data from PACS and RIS to identify and address failure points within the radiology workflow. The company's flagship product, Duali-Q, focuses on managing and following up on errors of omission in CT scans of the chest and abdomen. IMedis serves the healthcare industry, particularly hospitals and healthcare providers, aiming to reduce risk, improve financial efficacy, and create new business opportunities in digital healthcare and medical diagnostics.
Strategic signal
In January 2021, IMedis secured CE approval for its radiology scans in the EU. This regulatory clearance is a critical validation for the company's technology, enabling market expansion into European healthcare systems and signaling to investors its capability to meet stringent international medical device standards.
Log in to access full profile ›Company Intelligence Q&A
- When was IMedis founded?
- IMedis was founded in January 2018 by Aviel Blumenfeld and Yitzi Pfeffer.
- What is Duali-Q?
- Duali-Q is IMedis's first commercially available module, designed for the management and follow-up of errors of omission in CT scans of the chest and the abdomen. It has been shown to increase detection rates of life-threatening diseases by 13% in studies.
- What regulatory approval did IMedis receive in 2021?
- In January 2021, IMedis received CE approval for its radiology scans in the EU, allowing its technology to be used in European markets.
- Which investor participated in IMedis's January 2020 funding round?
- In January 2020, IMedis secured funding from ExitValley through an Equity Crowdfunding campaign.
- Which investor led IMedis's April 2018 funding round?
- In April 2018, Sanara Ventures led IMedis's Pre-Seed funding round.